HBI Deals+Insights / M&A/IPOs
Mid-market private equity firm Bridgepoint Group has agreed to acquire US-based Obagi Medical, a dermatological skincare and aesthetics business, from Nasdaq-listed beauty and wellness group Waldencast, for an enterprise value of up to $460 million (~€399.00 million).





